Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Joseph Foss, MD

216.445.8137

Joseph Foss, MD

Appointed: 2005

No Patient Satisfaction Reviews
Joseph Foss, MD
Department: General Anesthesiology
Director, Clinical Research for General Anesthesiology
Location: Cleveland Clinic Main Campus
Mail Code E3-130
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.8137
WorkFax:216.444.9247
Surgeon:
No
Type of Doctor:
Adults Only

Biographical Sketch

Joseph Foss, MD, is the Director of Clinical Research for General Anesthesiology in the Department of Anesthesiology at Cleveland clinic’s main campus. His specialty interests include clinical research, pain research, and clinical pharmacology, general and ambulatory anesthesia.

Dr. Foss earned his medical degree from Brown University School of Medicine in Providence, R.I. He completed a surgical internship at the University of Oregon Health Sciences Center in Portland, Ore. He also completed an anesthesia residency and a clinical pharmacology fellowship at the University of Chicago Hospitals in Chicago, Ill.

He is a Diplomate with the American Board of Anesthesiology, and a member of several medical societies, including the American Medical Association, the Ohio Society of Anesthesiologists, the American Society of Anesthesiologists and the International Anesthesia Research Society, among others.

Dr. Foss has published a number of articles in peer-reviewed journals on various topics related to anesthesiology and pharmacology. He has also lectured on the topics.

Education & Fellowships

Fellowship - University of Chicago Hospitals
Clinical Pharmacology
Chicago, IL USA
1990
Residency - University of Chicago Hospitals
Anesthesiology
Chicago, IL USA
1989
Internship - University of Oregon Health Sciences Center
Transitional
Portland, OH USA
1986
Medical School - Brown University School of Medicine
Providence, RI USA
1985
Undergraduate - Warren Alpert Medical School of Brown University Rhode Island Hospital
Providence, RI USA
1981

Certifications

  • Anesthesiology

Specialty Interests

Clinical pharmacology, Clinical research, General and ambulatory anesthesia, General anesthesia, Pain research

Innovations & Patents

Developed a novel drug, methylnaltrexone, which is approved for the treatment of side effects of opioid pain medications.

Memberships

  • American Society of Anesthesiologists
  • International Anesthesia Research Society
  • American Society of Clinical Pharmacology and Therapeutics

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/12/2016, Dr. Foss has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Foss receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • NeuroTherpia, Inc.
  • Progenics Pharmaceuticals, Inc.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Foss may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

  • NeuroTherpia, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English